TITLE

Perspective: Prescribing advisors

AUTHOR(S)
Newland-Jones, Philip
PUB. DATE
December 2013
SOURCE
Diabetes & Primary Care;2013, Vol. 15 Issue 6, p290
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
The author comments on the increased cardiovascular disease risk associated with the use of the glucose-lowering agent sulphonylurea. He believes that formulary developers and prescribing advisors should be aware of the risks of hypoglycaemia prior to prescribing sulphonylureas. He suggests modernisation of the formularies and development of patient-centered approaches.
ACCESSION #
93461441

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics